Clostridium Difficile News and Research

RSS
Clostridium difficile is a type of bacterium found in human and animal waste. Clostridium difficile is a common cause of diarrhea that occurs in hospitals. It can also cause diarrhea or other intestinal disorders in patients treated with antibiotics.
Plans moving forward for Medizone International's hospital sterilization system, AsepticSure

Plans moving forward for Medizone International's hospital sterilization system, AsepticSure

Sanofi Pasteur uses PHT’s LogPad System and StudyWorks online portal for its Phase II trial

Sanofi Pasteur uses PHT’s LogPad System and StudyWorks online portal for its Phase II trial

Cubist Pharmaceuticals acquires Calixa Therapeutics

Cubist Pharmaceuticals acquires Calixa Therapeutics

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

Nanotherapeutics acquires Ramoplanin clinical program from Oscient Pharmaceuticals

Nanotherapeutics acquires Ramoplanin clinical program from Oscient Pharmaceuticals

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

Cubist Pharmaceuticals signs definitive agreement to acquire Calixa Therapeutics

Cubist Pharmaceuticals signs definitive agreement to acquire Calixa Therapeutics

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff

Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff

BD acquires HandyLab for $275 million

BD acquires HandyLab for $275 million

AvidBiotics granted U.S. and European patents concerning its DGR technology platform

AvidBiotics granted U.S. and European patents concerning its DGR technology platform

Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study

Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study

Unexpected consequences emerge in patients who are prescribed PPI medications for reflux diseases

Unexpected consequences emerge in patients who are prescribed PPI medications for reflux diseases

Gen-Probe receives FDA emergency use authorization for its Prodesse ProFlu-ST test

Gen-Probe receives FDA emergency use authorization for its Prodesse ProFlu-ST test

NIH awards Excelimmune grant to develop treatment for Clostridium difficile infection

NIH awards Excelimmune grant to develop treatment for Clostridium difficile infection

HHS funds projects to combat health care-associated infections

HHS funds projects to combat health care-associated infections

Stomach infection on the rise in outpatient settings; symptoms can range from diarrhea to life-threatening inflammation

Stomach infection on the rise in outpatient settings; symptoms can range from diarrhea to life-threatening inflammation

BD to acquire HandyLab

BD to acquire HandyLab

HHS funds $17M for fight against costly and dangerous health care-associated infections

HHS funds $17M for fight against costly and dangerous health care-associated infections